| Chromatin loops in gene regulation S Kadauke, GA Blobel Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1789 (1), 17-25, 2009 | 308 | 2009 |
| Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes JM Lamonica, W Deng, S Kadauke, AE Campbell, R Gamsjaeger, ... Proceedings of the National Academy of Sciences 108 (22), E159-E168, 2011 | 251 | 2011 |
| Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1 S Kadauke, MI Udugama, JM Pawlicki, JC Achtman, DP Jain, Y Cheng, ... Cell 150 (4), 725-737, 2012 | 246 | 2012 |
| A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit GA Blobel, S Kadauke, E Wang, AW Lau, J Zuber, MM Chou, CR Vakoc Molecular cell 36 (6), 970-983, 2009 | 215 | 2009 |
| Mitotic bookmarking by transcription factors S Kadauke, GA Blobel Epigenetics & chromatin 6, 1-10, 2013 | 192 | 2013 |
| Risk-adapted preemptive tocilizumab to prevent severe cytokine release syndrome after CTL019 for pediatric B-cell acute lymphoblastic leukemia: a prospective clinical trial S Kadauke, RM Myers, Y Li, R Aplenc, D Baniewicz, DM Barrett, ... Journal of Clinical Oncology 39 (8), 920-930, 2021 | 137 | 2021 |
| Functions of BET proteins in erythroid gene expression AJ Stonestrom, SC Hsu, KS Jahn, P Huang, CA Keller, BM Giardine, ... Blood, The Journal of the American Society of Hematology 125 (18), 2825-2834, 2015 | 119 | 2015 |
| Activated protein C resistance testing for factor VL eiden S Kadauke, B Khor, EM Van Cott American journal of hematology 89 (12), 1147-1150, 2014 | 59 | 2014 |
| New directions in chimeric antigen receptor T cell [CAR‐T] therapy and related flow cytometry E Maryamchik, KME Gallagher, FI Preffer, S Kadauke, MV Maus Cytometry Part B: Clinical Cytometry 98 (4), 299-327, 2020 | 33 | 2020 |
| Outcomes after reinfusion of CD19-specific chimeric antigen receptor (CAR)-modified T cells in children and young adults with relapsed/refractory B-cell acute lymphoblastic … RM Myers, K Devine, Y Li, S Lawrence, AB Leahy, H Liu, L Vernau, ... Blood 138, 474, 2021 | 18 | 2021 |
| Red blood cell alloantibodies are associated with increased alloimmunization against human leukocyte antigens R Belizaire, J Mack, S Kadauke, Y Kim, S Saidman, RS Makar Transfusion 59 (7), 2256-2263, 2019 | 18 | 2019 |
| Early administration of tocilizumab (Toci) for the prevention of grade 4 cytokine release syndrome (CRS) after CD19-directed CAR T-cell therapy (CTL019) S Kadauke, S Maude, W Gladney, L Motley, V Shenoy, C Callahan, ... Cytotherapy 21 (5), e2-e3, 2019 | 16 | 2019 |
| Risk-adapted preemptive tocilizumab decreases severe cytokine release syndrome (CRS) after CTL019 CD19-targeted chimeric antigen receptor (CAR) T-cell therapy for pediatric B … RM Myers, S Kadauke, Y Li, CA Callahan, W Gladney, JC Fitzgerald, ... Biology of Blood and Marrow Transplantation 26 (3), S39, 2020 | 15 | 2020 |
| Building a robust tumor profiling program: synergy between next-generation sequencing and targeted single-gene testing MC Hiemenz, S Kadauke, DB Lieberman, DB Roth, J Zhao, CD Watt, ... PloS one 11 (4), e0152851, 2016 | 14 | 2016 |
| Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage S Uter, HH An, GE Linder, S Kadauke, D Sesok-Pizzini, HC Kim, ... Blood Advances 5 (12), 2586-2592, 2021 | 13 | 2021 |
| “Remembering” tissue-specific transcription patterns through mitosis S Kadauke, GA Blobel Cell Cycle 11 (21), 3911-3912, 2012 | 13 | 2012 |
| Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy H Newman, Y Li, H Liu, RM Myers, V Tam, A DiNofia, L Wray, ... Blood 141 (6), 609-619, 2023 | 11 | 2023 |
| Machine learning models improve the diagnostic yield of peripheral blood flow cytometry ML Zhang, AX Guo, S Kadauke, AS Dighe, JM Baron, AR Sohani American Journal of Clinical Pathology 153 (2), 235-242, 2020 | 11 | 2020 |
| Unrelated donor α/β T cell–and B cell–depleted HSCT for the treatment of pediatric acute leukemia AB Leahy, Y Li, JA Talano, CW Elgarten, AE Seif, Y Wang, B Johnson, ... Blood Advances 6 (4), 1175-1185, 2022 | 9 | 2022 |
| Compositions comprising a Brd4 antagonist and methods for the treatment of HIV TH Finkel, J Wang, G Blobel, S Kadauke US Patent 9,387,231, 2016 | 6 | 2016 |
Stephan A. GruppProfessor of Pediatrics, University of Pennsylvania School of Medicineכתובת אימייל מאומתת בדומיין chop.edu
